Melittin: a possible regulator of cancer proliferation in preclinical cell culture and animal models
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Melittin: a possible regulator of cancer proliferation in preclinical cell culture and animal models
Authors
Keywords
-
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-03
DOI
10.1007/s00432-023-05458-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apoptotic and antimetastatic effect of cucurbitacins in cancer: recent trends and advancement
- (2023) Ajay Kumar et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Chemopreventive mechanisms of amentoflavone: recent trends and advancements
- (2023) Hardeep Singh Tuli et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Genistein: a promising modulator of apoptosis and survival signaling in cancer
- (2023) Hemant Joshi et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Mellitin peptide quantification in seasonally collected crude bee venom and its anticancer effects on myelogenous K562 human leukaemia cell line
- (2023) Maher Obeidat et al. BMC Complementary Medicine and Therapies
- Wogonin, as a potent anticancer compound: From chemistry to cellular interactions
- (2023) Hardeep Singh Tuli et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers
- (2023) Pratibha Pandey et al. Nutrients
- Increased Pro-Apoptotic and Anti-Proliferative Activities of Simvastatin Encapsulated PCL-PEG Nanoparticles on Human Breast Cancer Adenocarcinoma Cells
- (2022) Mehdi Dadashpour et al. JOURNAL OF CLUSTER SCIENCE
- Sweet Bee Venom Triggers Multiple Cell Death Pathways or Spurs Acute Cell Rupture According to Its Concentration in THP-1 Monocytic Leukemia Cells
- (2022) Jae-Min Ryu et al. Genes
- Application of decellularized bone matrix as a bioscaffold in bone tissue engineering
- (2022) Halimeh Amirazad et al. Journal of Biological Engineering
- Melittin-Based Nano-Delivery Systems for Cancer Therapy
- (2022) Anqi Wang et al. Biomolecules
- Cancer combination therapies by angiogenesis inhibitors; a comprehensive review
- (2022) Mohammad Javed Ansari et al. Cell Communication and Signaling
- Therapeutic Effect of Melittin–dKLA Targeting Tumor-Associated Macrophages in Melanoma
- (2022) Ik-Hwan Han et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Melittin-derived peptides exhibit variations in cytotoxicity and antioxidant, anti-inflammatory and allergenic activities
- (2022) Haesoo Jung et al. Animal Cells and Systems
- Potentiality of raloxifene loaded melittin functionalized lipidic nanovesicles against pancreatic cancer cells
- (2022) Usama A. Fahmy et al. DRUG DELIVERY
- Melittin induces ferroptosis and ER stress-CHOP-mediated apoptosis in A549 cells
- (2022) Xuan Li et al. FREE RADICAL RESEARCH
- Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
- (2022) Soyoung Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bee Venom Triggers Autophagy-Induced Apoptosis in Human Lung Cancer Cells via the mTOR Signaling Pathway
- (2022) Ji Eun Yu et al. Journal of Oncology
- Melittin inhibits lung metastasis of human osteosarcoma: Evidence of wnt/β-catenin signaling pathway participation
- (2021) Haixia Zhu et al. TOXICON
- Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells
- (2021) Ghada H. Mansour et al. BIOORGANIC CHEMISTRY
- Co-delivery of metformin and silibinin in dual-drug loaded nanoparticles synergistically improves chemotherapy in human non-small cell lung cancer A549 cells
- (2021) Fereshteh Mogheri et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response
- (2020) Xiang Yu et al. Nature Communications
- Melittin—A Natural Peptide from Bee Venom Which Induces Apoptosis in Human Leukaemia Cells
- (2020) Michal Ceremuga et al. Biomolecules
- Anti-fungal properties and mechanisms of melittin
- (2020) Hamed Memariani et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- In vitro evidence of NLRP3 inflammasome regulation by histone demethylase LSD2 in renal cancer: a pilot study
- (2020) Aman Kumar et al. MOLECULAR BIOLOGY REPORTS
- Garcinol Exhibits Anti-Neoplastic Effects by Targeting Diverse Oncogenic Factors in Tumor Cells
- (2020) Vaishali Aggarwal et al. Biomedicines
- Metformin and Silibinin co-loaded PLGA-PEG nanoparticles for effective combination therapy against human breast cancer cells
- (2020) Soumaye Amirsaadat et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer
- (2020) Ciara Duffy et al. npj Precision Oncology
- Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance
- (2020) Hardeep Singh Tuli et al. SEMINARS IN CANCER BIOLOGY
- Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo
- (2019) Rezvan Yazdian-Robati et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Bee Venom and Its Peptide Component Melittin Suppress Growth and Migration of Melanoma Cells via Inhibition of PI3K/AKT/mTOR and MAPK Pathways
- (2019) Haet Lim et al. MOLECULES
- Melittin Inhibits Hypoxia-Induced Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition through Suppression of HIF-1α/Akt Pathway in Liver Cancer
- (2019) Qunwei Chen et al. Evidence-based Complementary and Alternative Medicine
- Melittin: a venom-derived peptide with promising anti-viral properties
- (2019) Hamed Memariani et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests
- (2019) Rim Wehbe et al. MOLECULES
- Synergistic Effects of Melittin and Plasma Treatment: A Promising Approach for Cancer Therapy
- (2019) Priyanka Shaw et al. Cancers
- Melittin inhibits proliferation, migration and invasion of bladder cancer cells by regulating key genes based on bioinformatics and experimental assays
- (2019) Jie Yao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Graphene oxide-based magnetic nanocomposites for the delivery of melittin to cervical cancer HeLa cells
- (2019) Jinxia Qi et al. NANOTECHNOLOGY
- The membrane effects of melittin on gastric and colorectal cancer
- (2019) Caroline Soliman et al. PLoS One
- In-vitro Detection of Phytopathogenic Fungal Cell Wall by Polyclonal Sera Raised Against Trimethyl Chitosan Nanoparticles
- (2019) Hemant Joshi et al. International Journal of Nanomedicine
- Use of Selected Carbon Nanoparticles as Melittin Carriers for MCF-7 and MDA-MB-231 Human Breast Cancer Cells
- (2019) Karolina Daniluk et al. Materials
- Anti-Inflammatory Effect of Melittin on Porphyromonas Gingivalis LPS-Stimulated Human Keratinocytes
- (2018) Woon-Hae Kim et al. MOLECULES
- CXCR4-directed theranostics in oncology and inflammation
- (2018) Malte Kircher et al. ANNALS OF NUCLEAR MEDICINE
- Synergistic co-delivery of doxorubicin and melittin using functionalized magnetic nanoparticles for cancer treatment: loading and in vitro release study by LC–MS/MS
- (2018) Marjan Hematyar et al. Artificial Cells Nanomedicine and Biotechnology
- Apoptotic Effect of Melittin Purified from Iranian Honey Bee Venom on Human Cervical Cancer HeLa Cell Line
- (2017) Hannaneh Zarrinnahad et al. International Journal of Peptide Research and Therapeutics
- Melittin exerts an antitumor effect on non-small cell lung cancer cells
- (2017) Su-Fang Zhang et al. Molecular Medicine Reports
- Diet phytochemicals and cutaneous carcinoma chemoprevention: A review
- (2017) Siliang Wang et al. PHARMACOLOGICAL RESEARCH
- Emerging Importance of Phytochemicals in Regulation of Stem Cells Fate via Signaling Pathways
- (2017) Mehdi Dadashpour et al. PHYTOTHERAPY RESEARCH
- Suppression of Hepatic Epithelial-to-Mesenchymal Transition by Melittin via Blocking of TGFβ/Smad and MAPK-JNK Signaling Pathways
- (2017) Ji-Hyun Park et al. Toxins
- Chemically different non-thermal plasmas target distinct cell death pathways
- (2017) Oleg Lunov et al. Scientific Reports
- A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency
- (2016) Simone Punt et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Current Challenges in Cancer Treatment
- (2016) Jon Zugazagoitia et al. CLINICAL THERAPEUTICS
- Melittin inhibits tumor angiogenesis modulated by endothelial progenitor cells associated with the SDF-1α/CXCR4 signaling pathway in a UMR-106 osteosarcoma xenograft mouse model
- (2016) GANG QIN et al. Molecular Medicine Reports
- Anti-Inflammatory Applications of Melittin, a Major Component of Bee Venom: Detailed Mechanism of Action and Adverse Effects
- (2016) Gihyun Lee et al. MOLECULES
- Melittin induces human gastric cancer cell apoptosisviaactivation of mitochondrial pathway
- (2016) Gui-Mei Kong et al. WORLD JOURNAL OF GASTROENTEROLOGY
- First report on the isolation of melittin from Iranian honey bee venom and evaluation of its toxicity on gastric cancer AGS cells
- (2015) Amir Mahmoodzadeh et al. Journal of the Chinese Medical Association
- Melittin induces PTCH1 expression by down-regulating MeCP2 in human hepatocellular carcinoma SMMC-7721 cells
- (2015) Xiaoqin Wu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Melittin suppresses cathepsin S-induced invasion and angiogenesis via blocking of the VEGF-A/VEGFR-2/MEK1/ERK1/2 pathway in human hepatocellular carcinoma
- (2015) ZHI ZHANG et al. Oncology Letters
- Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B
- (2015) Jie Zheng et al. Oncotarget
- Dual secured nano-melittin for the safe and effective eradication of cancer cells
- (2015) Bei Cheng et al. Journal of Materials Chemistry B
- Cancer chemoprevention is not a failure
- (2014) Vaqar Mustafa Adhami et al. CARCINOGENESIS
- Melittin–glutathione S-transferase fusion protein exhibits anti-inflammatory properties and minimal toxicity
- (2014) Jamie E. Rayahin et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells
- (2014) Yun-Jeong Jeong et al. FOOD AND CHEMICAL TOXICOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Cationic Antimicrobial Peptides Cytotoxicity on Mammalian Cells: An Analysis Using Therapeutic Index Integrative Concept
- (2014) M. Bacalum et al. International Journal of Peptide Research and Therapeutics
- The Protective Effects of Melittin on Propionibacterium acnes –Induced Inflammatory Responses In Vitro and In Vivo
- (2014) Woo-Ram Lee et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Melittin Restores PTEN Expression by Down-Regulating HDAC2 in Human Hepatocelluar Carcinoma HepG2 Cells
- (2014) Hui Zhang et al. PLoS One
- Molecular Basis of NF-κB Signaling
- (2013) Johanna Napetschnig et al. Annual Review of Biophysics
- The effect of acteoside on intracellular Ca2+ mobilization and phospholipase C activity in RBL-2H3 cells stimulated by melittin
- (2013) Jeong Soo Ryu et al. ARCHIVES OF PHARMACAL RESEARCH
- Melittin Suppresses HIF-1α/VEGF Expression through Inhibition of ERK and mTOR/p70S6K Pathway in Human Cervical Carcinoma Cells
- (2013) Jae-Moon Shin et al. PLoS One
- Tumour suppressor genes in chemotherapeutic drug response
- (2012) Dulcie Lai et al. BIOSCIENCE REPORTS
- Melittin Suppresses VEGF-A-Induced Tumor Growth by Blocking VEGFR-2 and the COX-2-Mediated MAPK Signaling Pathway
- (2012) Jeong-Eun Huh et al. JOURNAL OF NATURAL PRODUCTS
- Melittin Inhibits Atherosclerosis in LPS/High-Fat Treated Mice Through Atheroprotective Actions
- (2011) Soo-Jung Kim et al. Journal of Atherosclerosis and Thrombosis
- Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway
- (2011) Miran Jo et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Potentiation of anticancer-drug cytotoxicity by sea anemone pore-forming proteins in human glioblastoma cells
- (2010) Rossana C. Soletti et al. ANTI-CANCER DRUGS
- Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-κB and AP-1-dependent MMP-9 expression
- (2010) Jung Hyun Park et al. MOLECULES AND CELLS
- Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-κB
- (2010) Mi Hee Park et al. PROSTATE
- Potentiation of Bleomycin Lethality in HeLa and V79 Cells by Bee Venom
- (2009) Nada Oršolić Arhiv za Higijenu Rada i Toksikologiju-Archives of Industrial Hygiene and Toxicology
- Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth
- (2009) Neelesh R. Soman et al. JOURNAL OF CLINICAL INVESTIGATION
- Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway
- (2008) Shujing Liu et al. HEPATOLOGY
- JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin
- (2008) Hye Park et al. Journal of Inflammation-London
- Synthesis and Characterization of Stable Fluorocarbon Nanostructures as Drug Delivery Vehicles for Cytolytic Peptides
- (2008) Neelesh R. Soman et al. NANO LETTERS
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started